Bone Marrow Transplantation

Top Story

Many nonelderly cancer survivors alter prescription drug use to save money

Many nonelderly cancer survivors alter prescription drug use to save money
February 21, 2017

Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in Cancer.

“Specifically, nonelderly cancer survivors were more likely to skip medication, delay filling a prescription, ask their doctor for lower-cost medication, and use alternative therapies for financial reasons compared with nonelderly individuals without a cancer history,” Ahmedin Jemal, DVM, PhD, vice president of surveillance and health services research at the American Cancer Society, said in a press release.

Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology

February 20, 2017
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results. In 2016, several new immunotherapies…

New ASH president: 'Extraordinary science' at genomic level must be brought to bedside

February 14, 2017
Kenneth C. Anderson, MD, director of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute, took over as…

FDA: More adolescents with cancer should be included in adult trials

February 13, 2017
Enrollment of adolescents in oncology trials remains significantly lower than that of children. Consequently, the FDA has urged the research community to enroll more…
In the Journals Plus

Many nonelderly cancer survivors alter prescription drug use to save money

February 21, 2017
Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an…

Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology

February 20, 2017
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results. In 2016, several new…

New ASH president: 'Extraordinary science' at genomic level must be brought to bedside

February 14, 2017
Kenneth C. Anderson, MD, director of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute…

FDA: More adolescents with cancer should be included in adult trials

February 13, 2017
Enrollment of adolescents in oncology trials remains significantly lower than that of children. Consequently, the FDA has urged the research…

In the Journals Plus

Use of metaphors may improve participation in clinical trials

February 11, 2017
The use of metaphors for explaining randomization could ease the difficulty in recruiting patients to participate in randomized clinical trials…

In the Journals Plus

HLA–identical sibling HSCT leads to high rate of 5-year survival in sickle cell disease

February 10, 2017
HLA–identical sibling transplantation showed promising long-term survival for children and adults with sickle cell disease, according to an…

‘Explosive growth’ of interventional oncology prompts formation of new society

February 10, 2017
The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established…

Eight updates in cancer prevention

February 10, 2017
National Cancer Prevention Month, established by a U.S. Senate resolution and observed every February since 2004, is intended to draw attention to…

Cover Story

Hem/oncs toe ‘line in the sand’ between quest for cure, overly aggressive end-of-life care

HemOnc Today, February 10, 2017
Patients with hematologic malignancies are significantly more likely than those with solid tumors to receive chemotherapy or spend time in the…

Point/Counter

Is hospitalization within the final 30 days of life appropriate for patients with hematologic malignancies?

HemOnc Today, February 10, 2017
POINT As both a practicing blood cancer specialist and a board-certified palliative medicine physician, I know how valuable palliative care services are…

More Headlines »
Advertisement
Advertisement